Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial.

Fie Juhl Vojdeman; Lone Bredo Pedersen; G Doreen te Raa; V Juvonen; Yvette Norden; Geir Erland Tjønnfjord; Eva Kimby; Maija Itälä-Remes; Anton W Langerak; Ludo M.  Evers; Thorsten Zenz; Marinus van Oers; Christian Geisler; Arnon P Kater; Carsten Niemann

Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial.

Fie Juhl Vojdeman, Lone Bredo Pedersen, G Doreen te Raa, V Juvonen, Yvette Norden, Geir Erland Tjønnfjord, Eva Kimby, Maija Itälä-Remes, Anton W Langerak, Ludo M. Evers, Thorsten Zenz, Marinus van Oers, Christian Geisler, Arnon P Kater, Carsten Niemann

Klinisk Biokemisk Afd.

Originalsprog	Engelsk
Publikationsdato	7 dec. 2017
Status	Udgivet - 7 dec. 2017

Citationsformater

Vojdeman, F. J., Pedersen, L. B., te Raa, G. D., Juvonen, V., Norden, Y., Tjønnfjord, G. E., Kimby, E., Itälä-Remes, M., Langerak, A. W., Evers, L. M., Zenz, T., van Oers, M., Geisler, C., Kater, A. P., & Niemann, C. (2017). Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial..

Vojdeman, FJ , Pedersen, LB, te Raa, GD, Juvonen, V, Norden, Y, Tjønnfjord, GE, Kimby, E, Itälä-Remes, M, Langerak, AW, Evers, LM, Zenz, T, van Oers, M, Geisler, C, Kater, AP & Niemann, C 2017, 'Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial.'.

@conference{64972e1b145041149800accf3d8d024c,

title = "Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial.",

author = "Vojdeman, {Fie Juhl} and Pedersen, {Lone Bredo} and {te Raa}, {G Doreen} and V Juvonen and Yvette Norden and Tj{\o}nnfjord, {Geir Erland} and Eva Kimby and Maija It{\"a}l{\"a}-Remes and Langerak, {Anton W} and Evers, {Ludo M.} and Thorsten Zenz and {van Oers}, Marinus and Christian Geisler and Kater, {Arnon P} and Carsten Niemann",

year = "2017",

month = dec,

day = "7",

language = "English",

}

TY - ABST

T1 - Patients with Chronic Lymphocytic Leukemia Belonging to the B-Cell Receptor Stereotypy Subset #2 Have Long Progression Free Survival after Chemo- or Chemoimmunotherapy in the HOVON68 Trial.

AU - Vojdeman, Fie Juhl

AU - Pedersen, Lone Bredo

AU - te Raa, G Doreen

AU - Juvonen, V

AU - Norden, Yvette

AU - Tjønnfjord, Geir Erland

AU - Kimby, Eva

AU - Itälä-Remes, Maija

AU - Langerak, Anton W

AU - Evers, Ludo M.

AU - Zenz, Thorsten

AU - van Oers, Marinus

AU - Geisler, Christian

AU - Kater, Arnon P

AU - Niemann, Carsten

PY - 2017/12/7

Y1 - 2017/12/7

M3 - Conference abstract for conference

ER -